Robert Abels

3.8k total citations
35 papers, 2.7k citations indexed

About

Robert Abels is a scholar working on Hematology, Biochemistry and Genetics. According to data from OpenAlex, Robert Abels has authored 35 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 8 papers in Biochemistry and 7 papers in Genetics. Recurrent topics in Robert Abels's work include Erythropoietin and Anemia Treatment (22 papers), Blood transfusion and management (8 papers) and Hemoglobinopathies and Related Disorders (7 papers). Robert Abels is often cited by papers focused on Erythropoietin and Anemia Treatment (22 papers), Blood transfusion and management (8 papers) and Hemoglobinopathies and Related Disorders (7 papers). Robert Abels collaborates with scholars based in United States and Hungary. Robert Abels's co-authors include Michael R. Kelly, Nancy Haley, John W. Adamson, Joseph W. Eschbach, David H. Henry, Merrill A. Ritter, Philip M. Faris, Seth A. Rudnick, Thomas H. Price and Kay Larholt and has published in prestigious journals such as New England Journal of Medicine, JNCI Journal of the National Cancer Institute and PEDIATRICS.

In The Last Decade

Robert Abels

32 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Abels United States 21 1.9k 980 639 393 387 35 2.7k
Timothy J. Littlewood United Kingdom 29 2.4k 1.3× 389 0.4× 884 1.4× 135 0.3× 425 1.1× 61 3.2k
Martin R. Schipperus Netherlands 23 1.4k 0.7× 592 0.6× 441 0.7× 75 0.2× 122 0.3× 92 2.1k
Janice G. McFarland United States 36 2.7k 1.4× 1.0k 1.1× 320 0.5× 113 0.3× 135 0.3× 74 4.2k
J. Ingerslev Denmark 33 2.8k 1.4× 432 0.4× 585 0.9× 112 0.3× 94 0.2× 97 4.2k
Nicholas Bandarenko United States 19 616 0.3× 196 0.2× 321 0.5× 299 0.8× 92 0.2× 36 1.9k
Stanley E. Gräber United States 18 1.1k 0.6× 164 0.2× 364 0.6× 338 0.9× 138 0.4× 42 1.7k
James P. Isbister Australia 25 554 0.3× 933 1.0× 224 0.4× 33 0.1× 196 0.5× 113 2.1k
Stefan Lethagen Sweden 32 2.2k 1.1× 311 0.3× 483 0.8× 54 0.1× 70 0.2× 125 3.1k
J. G. Kelton Canada 19 1.1k 0.6× 337 0.3× 171 0.3× 45 0.1× 79 0.2× 28 2.1k
Federico Lussana Italy 23 1.2k 0.6× 51 0.1× 692 1.1× 175 0.4× 229 0.6× 63 2.3k

Countries citing papers authored by Robert Abels

Since Specialization
Citations

This map shows the geographic impact of Robert Abels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Abels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Abels more than expected).

Fields of papers citing papers by Robert Abels

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Abels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Abels. The network helps show where Robert Abels may publish in the future.

Co-authorship network of co-authors of Robert Abels

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Abels. A scholar is included among the top collaborators of Robert Abels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Abels. Robert Abels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garnick, Marc B., Robert Abels, & Seth A. Rudnick. (2015). The Role of Recombinant Human Erythropoietin in the Management of Anemia Associated with Acquired Immunodeficiency Syndrome. Contributions to nephrology. 88. 282–294.
2.
Hecken, Anne Van, Marleen Depré, Jozef Arnout, et al.. (1998). Pharmacodynamics and pharmacokinetics of RWJ-53308, a nonpeptide platelet glycoprotein IIb/IIIa receptor antagonist, in healthy men. Naunyn-Schmiedeberg s Archives of Pharmacology. 358(1). 1 indexed citations
3.
Price, Thomas H., Lawrence T. Goodnough, William R. Vogler, et al.. (1996). The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: a multicenter, randomized, double‐blind, controlled trial. Transfusion. 36(1). 29–36. 64 indexed citations
4.
Price, Thomas H., Lawrence T. Goodnough, William R. Vogler, et al.. (1996). Improving the efficacy of preoperative autologous blood donation in patients with low hematocrit: A randomized, double-blind, controlled trial of recombinant human erythropoietin. The American Journal of Medicine. 101(2). 22S–27S. 22 indexed citations
5.
Rose, Esther, et al.. (1995). The use of r‐HuEpo in the treatment of anaemia related to myelodysplasia (MDS). British Journal of Haematology. 89(4). 831–837. 80 indexed citations
6.
Roth, David, Ronald D. Smith, Gerald Schulman, et al.. (1994). Effects of Recombinant Human Erythropoietin on Renal Function in Chronic Renal Failure Predialysis Patients. American Journal of Kidney Diseases. 24(5). 777–784. 133 indexed citations
7.
Goodnough, Lawrence T., Thomas H. Price, Kenneth D. Friedman, et al.. (1994). A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy. Transfusion. 34(1). 66–71. 98 indexed citations
8.
Case, Delvyn C., Robert W. Carey, David H. Henry, et al.. (1993). Recombinant Human Erythropoietin Therapy for Anemic Cancer Patients on Combination Chemotherapy. JNCI Journal of the National Cancer Institute. 85(10). 801–806. 154 indexed citations
9.
Shannon, Kevin, et al.. (1992). Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: A pilot study. The Journal of Pediatrics. 120(4). 586–592. 73 indexed citations
10.
Rose, Esther, Seth A. Rudnick, Robert Abels, et al.. (1991). Efficacy and safety of recombinant human erythropoietin r huepo in anemic patients with myelodysplastic syndromes. Leukemia Research. 15. 13. 6 indexed citations
11.
Shannon, Kevin, William C. Mentzer, Robert Abels, et al.. (1991). Recombinant human erythropoietin in the anemia of prematurity: Results of a placebo-controlled pilot study. The Journal of Pediatrics. 118(6). 949–955. 119 indexed citations
12.
Abels, Robert, et al.. (1991). Recombinant human erythropoietin (r-HuEPO) for the treatment of the anemia of cancer. Stem Cells. 9(S1). 121–141. 79 indexed citations
13.
Fischl, Margaret A., Jeffrey E. Galpin, James D. Levine, et al.. (1990). Recombinant Human Erythropoietin for Patients with AIDS Treated with Zidovudine. New England Journal of Medicine. 322(21). 1488–1493. 272 indexed citations
14.
Goodnough, Lawrence T., Seth A. Rudnick, Thomas H. Price, et al.. (1989). Increased Preoperative Collection of Autologous Blood with Recombinant Human Erythropoietin Therapy. New England Journal of Medicine. 321(17). 1163–1168. 335 indexed citations
15.
Eschbach, Joseph W., Michael R. Kelly, Nancy Haley, Robert Abels, & John W. Adamson. (1989). Treatment of the Anemia of Progressive Renal Failure with Recombinant Human Erythropoietin. New England Journal of Medicine. 321(3). 158–163. 370 indexed citations
16.
Huang, Shiew‐Mei, Thomas B. Marriott, Howard Weintraub, et al.. (1988). Single-dose and multiple-dose pharmacokinetics of etintidine in healthy volunteers. European Journal of Clinical Pharmacology. 34(1). 101–104. 5 indexed citations
17.
Huang, Shiew‐Mei, Howard Weintraub, Robert Abels, et al.. (1988). Clinical pharmacokinetics of etintidine. Biopharmaceutics & Drug Disposition. 9(5). 477–486. 5 indexed citations
18.
Sm, Huang, et al.. (1988). The effect of food or milk on the bioavailability of etintidine in healthy subjects.. PubMed. 26(3). 113–7. 1 indexed citations
19.
Huang, Shiew‐Mei, et al.. (1987). Etintidine‐theophylline interaction study in humans. Biopharmaceutics & Drug Disposition. 8(6). 561–569. 6 indexed citations
20.
Huang, Shiew‐Mei, et al.. (1987). Etintidine-propranolol interaction study in humans. Journal of Pharmacokinetics and Biopharmaceutics. 15(6). 557–568. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Timothy J. Littlewood Breakdown of academic impact, for papers by Martin R. Schipperus Breakdown of academic impact, for papers by Janice G. McFarland Breakdown of academic impact, for papers by J. Ingerslev Breakdown of academic impact, for papers by Nicholas Bandarenko Breakdown of academic impact, for papers by Stanley E. Gräber Breakdown of academic impact, for papers by James P. Isbister Breakdown of academic impact, for papers by Stefan Lethagen Breakdown of academic impact, for papers by J. G. Kelton Breakdown of academic impact, for papers by Federico Lussana
Rankless by CCL
2026